A detailed history of Susquehanna International Group, LLP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 142,717 shares of SWTX stock, worth $4.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
142,717
Previous 238,545 40.17%
Holding current value
$4.27 Million
Previous $11.7 Million 54.21%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$36.06 - $47.62 $3.46 Million - $4.56 Million
-95,828 Reduced 40.17%
142,717 $5.38 Million
Q1 2024

May 07, 2024

BUY
$36.5 - $52.5 $3.94 Million - $5.66 Million
107,886 Added 82.57%
238,545 $11.7 Million
Q4 2023

Feb 14, 2024

BUY
$18.94 - $37.24 $1.71 Million - $3.37 Million
90,429 Added 224.78%
130,659 $4.77 Million
Q3 2023

Nov 14, 2023

SELL
$23.12 - $31.38 $78,492 - $106,535
-3,395 Reduced 7.78%
40,230 $930,000
Q2 2023

Aug 11, 2023

SELL
$23.15 - $32.71 $1.94 Million - $2.75 Million
-83,924 Reduced 65.8%
43,625 $1.14 Million
Q1 2023

May 16, 2023

BUY
$24.97 - $34.05 $2.58 Million - $3.52 Million
103,499 Added 430.35%
127,549 $3.28 Million
Q4 2022

Feb 14, 2023

SELL
$21.73 - $28.72 $1.86 Million - $2.45 Million
-85,408 Reduced 78.03%
24,050 $625,000
Q3 2022

Nov 14, 2022

BUY
$24.1 - $39.66 $816,749 - $1.34 Million
33,890 Added 44.85%
109,458 $3.12 Million
Q2 2022

Aug 15, 2022

BUY
$18.36 - $60.07 $968,949 - $3.17 Million
52,775 Added 231.54%
75,568 $1.86 Million
Q1 2022

May 16, 2022

SELL
$48.97 - $65.46 $821,471 - $1.1 Million
-16,775 Reduced 42.4%
22,793 $1.29 Million
Q4 2021

Feb 14, 2022

BUY
$53.3 - $75.84 $732,555 - $1.04 Million
13,744 Added 53.22%
39,568 $2.45 Million
Q3 2021

Nov 15, 2021

BUY
$62.66 - $88.26 $902,617 - $1.27 Million
14,405 Added 126.15%
25,824 $1.64 Million
Q2 2021

Aug 11, 2021

SELL
$67.45 - $85.63 $298,803 - $379,340
-4,430 Reduced 27.95%
11,419 $941,000
Q1 2021

May 17, 2021

BUY
$65.1 - $93.59 $187,357 - $269,352
2,878 Added 22.19%
15,849 $1.17 Million
Q4 2020

Feb 16, 2021

BUY
$48.36 - $77.92 $627,277 - $1.01 Million
12,971 New
12,971 $941,000
Q4 2019

Feb 14, 2020

SELL
$17.74 - $39.52 $255,314 - $568,771
-14,392 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$18.8 - $27.82 $270,569 - $400,385
14,392 New
14,392 $312,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $1.87B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.